#LocallyAdvanced - Twitter Hashtag

6 days ago

Randomised (non-conparative) study #LocallyAdvanced #PDAC at @myESMO #ESMOGI26 👉FOLFIRINOX 👉FOLFIRINOX + P-32 EUS-guided brachytherapy (100Gy) Similar local disease control (1ry end-point) and resection rate BUT, may improve PR, R0, PFS and OS (see comment) #ESMOAmbassadors

DrAngelaLamarca's tweet photo. Randomised (non-conparative) study #LocallyAdvanced #PDAC at @myESMO #ESMOGI26

👉FOLFIRINOX
👉FOLFIRINOX + P-32 EUS-guided brachytherapy (100Gy)

Similar local disease control (1ry end-point) and resection rate

BUT, may improve PR, R0, PFS and OS (see comment)

#ESMOAmbassadors https://t.co/JF2rXBe6lB

1

13

7

1

1K

Rami Manochakian MD, FASCO Cancer Education

@RManochakian

almost 2 years ago

🔥🚨 @OncoAlert Hot off the press. As expected, @US_FDA approves #Osimertinib for #locallyadvanced #EGFR+ #NSCLC following concurrent or sequential #Chemoradiation. Approval based on #Laura trial: ⬆️#mPFS 39.1 (Osi) vs 5.6 months (placebo). HR 0.16 👇🏼 https://t.co/J1bZQmQPlO

RManochakian's tweet photo. 🔥🚨 @OncoAlert Hot off the press.

As expected, @US_FDA approves #Osimertinib for #locallyadvanced #EGFR+ #NSCLC following concurrent or sequential #Chemoradiation.

Approval based on #Laura trial:

⬆️#mPFS 39.1 (Osi) vs 5.6 months (placebo). HR 0.16

👇🏼
https://t.co/J1bZQmQPlO https://t.co/qNdBwrwSLx

3

56

22

3

10K

GU Oncology Now @GUOncologyNow

almost 2 years ago

Incoming ✈️ #ESMO24 data from @tompowles1 on #PFS and #OS benefit with #EVplusPembro in #metastatic #locallyadvanced #urothelialcarcinoma across all #subgroups. 🧠 Learn more: https://t.co/IWDxj09gip

GUOncologyNow's tweet photo. Incoming ✈️ #ESMO24 data from @tompowles1 on #PFS and #OS benefit with #EVplusPembro in #metastatic #locallyadvanced #urothelialcarcinoma across all #subgroups.

🧠 Learn more: https://t.co/IWDxj09gip https://t.co/tcmukjSRhn

0

2

0

211

Misty Dawn Shields

@drshieldsmd

over 2 years ago

Novel approaches to #locallyadvanced landscape for #NSCLC including #CCRT #immunotherapy expertly discussed by the fabulous @ChristineBestv1 from @UCCancerCenter at the #IULungSymposium #LCSM #EndLungCancerNow @IUCancerCenter @IUPUI @gdurm @BigTenCRC

drshieldsmd's tweet photo. Novel approaches to #locallyadvanced landscape for #NSCLC including #CCRT #immunotherapy expertly discussed by the fabulous @ChristineBestv1 from @UCCancerCenter at the #IULungSymposium

#LCSM #EndLungCancerNow @IUCancerCenter @IUPUI @gdurm @BigTenCRC https://t.co/vB8Qw2SbT4

0

20

3

0

1K

BJS

@BJSurgery

over 2 years ago

#polltime ⁉️Do you employ neoadjuvant therapy for #locallyadvanced colon cancer? Share your approach #neoadjuvanttherapy #cancertherapy #SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @des_winter @evanscolorectal @robhinchliffe1 @bplwijn @ksoreide @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @asgbi @ESCP_tweets @YouESCP

1

9

10

0

3K

Andrea D'Aviero @AndreaDav89

over 2 years ago

Interesting review on #borderlineresectable and #locallyadvanced #PDAC 📑 considerable variation in international #guidelines 🕳️ lacking of randomised controlled trials for #preop approach 🩻need of integration of #biological and #imaging response https://t.co/MyY7iBhgmO

1

2

1

0

80

James Glasbey 🇪🇺 @DrJamesGlasbey

over 3 years ago

Check out newly released @FoxtrotStudy mature results @ASCO @JCO_ASCO ✨ NAC safe and effective for #locallyadvanced #CRC @me4_so Will this change practice in your unit? 💊 @JenSeligmann

foxtrot-study @FoxtrotStudy

over 3 years ago

Our FOxTROT-1 mature results have just been released! @JCO_ASCO Preoperative chemotherapy is a safe and effective treatment option for locally advanced #coloncancer 💊 Huge thanks to @CRUKresearch @yorkshirecancer and all our international collaborators! 👏

FoxtrotStudy's tweet photo. Our FOxTROT-1 mature results have just been released! @JCO_ASCO

Preoperative chemotherapy is a safe and effective treatment option for locally advanced #coloncancer 💊

Huge thanks to @CRUKresearch @yorkshirecancer and all our international collaborators! 👏 https://t.co/vpDnBb2PSc

5

211

103

16

37K

0

4

1

0

344

Angelo Pirozzi @angelopirozzi3

almost 4 years ago

🔴The crucial question for #pancreaticcancer #prognosis is still "Is it resectable? " but criteria are debated and frequently updated 🤔🤔 This interesting #retrospective experience tries to identify more complete criteria in the #LocallyAdvanced stage👇

Syed A. Ahmad @SyedAAhmad5

almost 4 years ago

In the modern era neoadjuvant with multi agent therapy, radiographic response can be achieved 20-30% of time. In this series locally advanced pts were able to undergo resection 16% of time. @AnnSurgOncol @McMastersKelly @DavendraSohal @kharofaJ @TsengJennifer @RSnyder_MD

1

14

6

0

2

0

Young Surgeons Advisory Committee (YSAC) @YSAC_PK

almost 4 years ago

The Next @YSAC_PK online #SurgicalOncology #JournalClub will be held on Saturday 13 August 2022 5pm PKT [08:00 New York, 13:00 London, 14:00 Brussels, 21:00 Tokyo] discussing Real world outcomes of #LocallyAdvanced #BreastCancer @SOS_Pk @PkSurgeons https://t.co/anW3ZFvEPE

1

5

3

0

Claire Taylor @claire_taylor22

about 4 years ago · Edinburgh

Options for #locallyadvanced rectal cancer & LRRC which invades or abuts the sacrum #carefulplanning #teamwork #QOL #rehab @StMarksHospital

claire_taylor22's tweet photo. Options for #locallyadvanced rectal cancer & LRRC which invades or abuts the sacrum #carefulplanning #teamwork #QOL #rehab @StMarksHospital https://t.co/ggQb7FiZVl

0

27

6

0

Charu Aggarwal, MD, MPH, FASCO

@CharuAggarwalMD

about 5 years ago

While the data from KN-799 is intriguing, it does not replace the current standard of care currently. I remain intrigued at the possibility of using systemic dose chemotherapy with earlier integration of Immunotherapy in patients with #LocallyAdvanced #NSCLC #LCSM

CharuAggarwalMD's tweet photo. While the data from KN-799 is intriguing, it does not replace the current standard of care currently.

I remain intrigued at the possibility of using systemic dose chemotherapy with earlier integration of Immunotherapy in patients with #LocallyAdvanced #NSCLC #LCSM https://t.co/CQjemI5PGR

0

3

1

0

IBC Research Fdn @IBCResearch

about 5 years ago

The #IBC community faces this as well. We're usually thrown in with #locallyadvanced #breastcancer or just #metastaticdisease but IBC outcome may not be the same. Too few ppl to have meaningful data. #OpportunityLost Thanks for speaking up.

Leigh Pate @LPseattle

about 5 years ago

Patients with #Metastatic #lobular #breastcancer have long suspected this - we must FIX this to give patients access to trials and to study #ILC and learn differences. Thx @UCSFCancer @hoperugo and Rita Mukhtar for this research @LobularBCA @ASCO2021 @mbcalliance @OncoAlert

0

21

12

0

2

0

BreastCancerTrials.org @BCTrials

over 5 years ago

#bcsm #DrugApproval #mbc #clinicaltrials #LocallyAdvanced #StageIV #BreastCancer

Aditya Bardia, MD @dradityabardia

over 5 years ago

Wonderful news for patients and field. Kudos to trial volunteers who paved the way for future generation. Lot more needs to be done to further improve #MBC outcomes, including accelerating development of effective therapies and rational mechanistic-based combinations.#oncoalert

2

46

6

0

4

0

Nelson Royall, MD FACS @nelsonroyall

over 5 years ago

Great new addition on #LocallyAdvanced #PancreasCancer in Europe. Hard to determine who is best suited for the aggressive regimens, but those who complete have improved #Survival @PanCAN_Oklahoma @UticaParkClinic

Marc Besselink

@MarcBesselink

over 5 years ago

Locally advanced #PancreaticCancer prospective study in all-comers: 14 🇳🇱 centers, 422 pts; 77% chemo of whom 77% FOLFIRINOX. mOS entire cohort 10 months, FOLFIRINOX 14, gem-nab-paclitaxel 9. Resection after FFX: 13%, mOS 23 months. https://t.co/UShBwjFXJT #alvleesklierkanker